Dyslipidemias Clinical Trials

16 recruiting

Frequently Asked Questions

Common questions about Dyslipidemias clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

PILI 'Āina Household

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii210 enrolled2 locationsNCT06526273
Recruiting
Not Applicable

'Ai Pono Cooking Demonstrations

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii1,780 enrolled2 locationsNCT06526650
Recruiting

Taining Golden Lake Comprehensive Chronic Disease Management Initiative

SarcopeniaDiabetes MellitusHypertension+4 more
First Affiliated Hospital of Fujian Medical University20,000 enrolled1 locationNCT07308314
Recruiting
Phase 2

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting

Military Health and Nutrition Examination Study

Cardiovascular DiseasesHypertensionType 2 Diabetes+1 more
Pennington Biomedical Research Center650 enrolled3 locationsNCT06380322
Recruiting

Gut Microbiota in Metabolic Surgery

Cardiovascular DiseasesHypertensionType 2 Diabetes+3 more
Vanderbilt University Medical Center300 enrolled1 locationNCT05000996
Recruiting

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Diabetes MellitusHypertensionDyslipidemias
Beijing Tongren Hospital300 enrolled1 locationNCT05644548
Recruiting
Not Applicable

Culturally Adapted Dietary Clinical Trial in PR

ObesityHypertensionDiabetes Mellitus, Type 2+4 more
Harvard School of Public Health (HSPH)250 enrolled1 locationNCT05962372
Recruiting

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

HypertensionType 2 DiabetesHIV-1-infection+1 more
Duke University150 enrolled2 locationsNCT05129345
Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

ObesityCardiovascular DiseasesChronic Kidney Diseases+8 more
Swiss Tropical & Public Health Institute1,200 enrolled1 locationNCT05881447
Recruiting

Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico

ObesityCardiovascular DiseasesMetabolic Syndrome+13 more
Harvard School of Public Health (HSPH)2,000 enrolled1 locationNCT03794531
Recruiting
Not Applicable

Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease

HypertensionChronic Kidney DiseasesDyslipidemias
Yonsei University642 enrolled1 locationNCT06322056
Recruiting
Phase 1

To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults

Type 2 DiabetesDyslipidemias
Hyundai Pharm56 enrolled1 locationNCT06578676
Recruiting
Not Applicable

To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM

DyslipidemiasT2DM (Type 2 Diabetes Mellitus)
Korea University Anam Hospital3,958 enrolled1 locationNCT06293417
Recruiting

CArdioMetabolism and Atherosclerotic PlaqUe progreSsion

ObesityMetabolic SyndromeDiabetes Mellitus, Type 2+2 more
Ruijin Hospital3,000 enrolled1 locationNCT05117424
Recruiting
Phase 4

Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Diabetes Mellitus, Type 2AtherosclerosisDyslipidemias
Seoul National University Bundang Hospital105 enrolled1 locationNCT05365438